Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > News > McAdams Wright Ragen Initiates Coverage on FEI (NASDAQ: FEIC)

January 5th, 2011

McAdams Wright Ragen Initiates Coverage on FEI (NASDAQ: FEIC)

Abstract:
Equities research analysts at McAdams Wright Ragen initiated coverage on shares of FEI (NASDAQ: FEIC) in a research note to clients and investors on Monday. The analysts set a "hold" rating and a $29.00 price target on the stock.

Source:
americanbankingnews.com

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Researchers uncover strong light-matter interactions in quantum spin liquids: Groundbreaking experiment supported by Rice researcher reveals new insights into a mysterious phase of quantum matter December 13th, 2024

FSU researchers develop new methods to generate and improve magnetism of 2D materials December 13th, 2024

Innovative biomimetic superhydrophobic coating combines repair and buffering properties for superior anti-erosion December 13th, 2024

Groundbreaking research unveils unified theory for optical singularities in photonic microstructures December 13th, 2024

Announcements

Researchers uncover strong light-matter interactions in quantum spin liquids: Groundbreaking experiment supported by Rice researcher reveals new insights into a mysterious phase of quantum matter December 13th, 2024

FSU researchers develop new methods to generate and improve magnetism of 2D materials December 13th, 2024

Innovative biomimetic superhydrophobic coating combines repair and buffering properties for superior anti-erosion December 13th, 2024

Groundbreaking research unveils unified theory for optical singularities in photonic microstructures December 13th, 2024

Financial Reports

180 Degree Capital Corp. Reports +14.2% Growth in Q1 2021, $10.60 Net Asset Value Per Share as of March 31, 2021, and Developments From Q2 2021 May 11th, 2021

Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021

Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021

180 Degree Capital Corp. Reports +6.7% Growth in Q4 2020, $9.28 Net Asset Value per Share as of December 31, 2020, and Developments from Q1 2021 Including Expected Investment in a Planned SPAC Sponsor February 22nd, 2021

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project